The nurse is assessing a client who has undergone a percutaneous transluminal coronary angioplasty (PTCA)and is ordered to receive an IV infusion of abciximab (ReoPro).Which clinical manifestation does the nurse monitor for in this client?

Question

Quizplus · Accepted Answer

Administration of glycoprotein (GP)IIa/IIIb inhibitors is common during the first few hours after PTCA.The nurse should monitor the client closely for bleeding and hypersensitivity reactions,which can include angioedema,urticaria,and even anaphylaxis.The other manifestations are not associated with the administration of GP IIa/IIIb inhibitors.

The Nurse Is Assessing a Client Who Has Undergone a Percutaneous